Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs Palvella Therapeutics
Over the past year NAMS returned −42.7% and PVLA returned +116.2%; their daily moves had a correlation of 0.32.
NAMS −42.7% PVLA +116.2%Growth of $1, one year, split-adjusted
| Metric | NAMS | PVLA |
|---|---|---|
| Price | $20.93 | $162.28 |
| Market cap | $2.50B | $2.34B |
| Today | +5.18% | +6.11% |
| 1 month | −6.0% | +26.8% |
| 6 months | −32.5% | +24.7% |
| Year to date | −40.3% | +55.0% |
| 1 year | −43.4% | +111.2% |
| Revenue growth (YoY) | −80.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1732.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 351.3× | — |
| Net cash | $633.9M | $250.6M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 48.6% |
| Short % of float | 16.4% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).